Weekly THC units higher with initiation of cannabis for anxiety, for depression, or because family members were using it

In studies not testing for therapeutic effect, high-concentration THC products had unfavorable links with psychosis, schizophrenia

After addition of anxiety as qualifying condition, 60.26 percent of certifications were for anxiety

Prevalence of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids vaping higher for girls than boys

Vaping and dabbing are the most prevalent routes of use among persons aged 18 to 24 years

Significant declines seen across genders, races/ethnicities

Higher odds of past-month cannabis use linked to residing in states where cannabis is legal, past-year depressive episode

Prevalence was lower in Western versus Southern census regions, in states with regulations, in states with legal adult-use marijuana